160 related articles for article (PubMed ID: 8578548)
1. Role of tissue factor in disseminated intravascular coagulation.
Asakura H; Kamikubo Y; Goto A; Shiratori Y; Yamazaki M; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E
Thromb Res; 1995 Nov; 80(3):217-24. PubMed ID: 8578548
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation.
Wada H; Nakase T; Nakaya R; Minamikawa K; Wakita Y; Kaneko T; Ohiwa M; Deguchi K; Shirakawa S
Am J Hematol; 1994 Mar; 45(3):232-6. PubMed ID: 8296794
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelin in disseminated intravascular coagulation.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1992 Oct; 41(2):71-5. PubMed ID: 1415185
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
[TBL] [Abstract][Full Text] [Related]
5. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
6. Elevated tissue factor levels in leukemic cell homogenate.
Nakasaki T; Wada H; Watanabe R; Mori Y; Gabazza EC; Kageyama S; Nishikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jan; 6(1):14-7. PubMed ID: 10726043
[TBL] [Abstract][Full Text] [Related]
7. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases.
Sase T; Wada H; Kamikura Y; Kaneko T; Abe Y; Nishioka J; Nobori T; Shiku H
Thromb Haemost; 2004 Jul; 92(1):132-9. PubMed ID: 15213854
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Satoh N; Wada K; Takakuwa E; Seki Y; Shibata A
Am J Hematol; 1994 Aug; 46(4):333-7. PubMed ID: 8037186
[TBL] [Abstract][Full Text] [Related]
10. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.
Takahashi H; Sato N; Shibata A
Thromb Res; 1995 Nov; 80(4):339-48. PubMed ID: 8585047
[TBL] [Abstract][Full Text] [Related]
11. Microparticle-associated tissue factor activity in dogs with disseminated intravascular coagulation.
Kobayashi K; Baba K; Igase M; Miyama TS; Kambayashi S; Okuda M
J Vet Med Sci; 2020 Jan; 82(1):56-60. PubMed ID: 31787663
[TBL] [Abstract][Full Text] [Related]
12. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
[TBL] [Abstract][Full Text] [Related]
13. Changes in plasma levels of prothrombin fragment F 1 + 2 in cases of disseminated intravascular coagulation.
Asakura H; Shiratori Y; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Acta Haematol; 1993; 89(1):22-5. PubMed ID: 8480481
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation.
Matsumoto H; Yamakawa K; Ogura H; Koh T; Matsumoto N; Shimazu T
Shock; 2015 May; 43(5):443-9. PubMed ID: 25608138
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Dec; 38(4):281-7. PubMed ID: 1660674
[TBL] [Abstract][Full Text] [Related]
16. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Mar; 36(3):176-83. PubMed ID: 1899963
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients.
Gando S; Nanzaki S; Morimoto Y; Ishitani T; Kemmotsu O
Crit Care Med; 2001 Feb; 29(2):262-6. PubMed ID: 11246303
[TBL] [Abstract][Full Text] [Related]
18. miR-19a-3p downregulates tissue factor and functions as a potential therapeutic target for sepsis-induced disseminated intravascular coagulation.
Zhang R; Lu S; Yang X; Li M; Jia H; Liao J; Jing Q; Wu Y; Wang H; Xiao F; Bai X; Na X; Kang Y; Wan L; Yang J
Biochem Pharmacol; 2021 Oct; 192():114671. PubMed ID: 34246626
[TBL] [Abstract][Full Text] [Related]
19. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
20. The tissue factor pathway in disseminated intravascular coagulation.
Østerud B; Bjørklid E
Semin Thromb Hemost; 2001 Dec; 27(6):605-17. PubMed ID: 11740684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
